Reducing calories may help cognitive function in MS

Published Date: 02 Mar 2023

Multiple sclerosis patients who cut calories two days a week not only lost weight but also experienced better cognition and other benefits in a new study.

Read Full News

Latest News

What's Causing This Strange Constellation of Symptoms in an Older Woman?

Prompt assessment and treatment needed to prevent blindness, authors warn

What is Causing This MS Patient's Unusual Symptoms?

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Todays Updates

Rare Tumor in a Rare Location in Patient With Constipation

Could occupational exposure to sawdust explain this case?

Latest News

Prompt assessment and treatment needed to prevent blindness, authors warn

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

News All Time

Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate

News and commentary from the world of neurology and neuroscience

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

Recommended News For You

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Significant differences in breast cancer care still exist, but surgeons can change.

Lesser-known lobular breast cancer on the rise in U.S. women

Which Risk Model Better Identifies High-Risk Smoldering MM?

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

AI tool identifies women at high risk of interval breast cancer

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Recommended Articles For You

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer 

Care Coordination in Chronic Anemia: Mechanisms, Clinical Implications, and Emerging Strategies 

Hemophilia: Pathophysiology, Genetics, and Treatment Advances 

Clinical Frameworks in Hematology for Better Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

2.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

3.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

4.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.

5.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

1.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

2.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

3.

The New Era of Oncology: Key Updates and Clinical Insights

4.

How HLH is Revolutionizing Healthcare

5.

Digital Cancer Caregiver Coordination Platforms: Advances, Clinical Impact, and Future Directions

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

How Advances in Cancer Research Are Improving Treatment Options

2.

From Guidelines to Practice: Hematology

3.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

4.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot